CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations.

Our compounded experiences are rooted in broad pharmaceutical R&D, astute business transactions and hands-on governance. We seek highly differentiated and scalable ideas, that we will chaperone forward to growth.